We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Zhenhua Wu is the CEO of NeuExcell Therapeutics. Previously he was the Vice President, Head of Preclinical Development of United Neuroscience, overseeing strategy and execution of preclinical research and development. Prior to UNS, he was Director of Neuroscience Therapeutic Area at GlaxoSmithKline, where he served as a global project lead focusing on therapies for neurodegenerative and neuroinflammatory diseases. He had previously worked in various functional areas in Merck & Co. for ten years where he led various neuroscience projects. Zhenhua received his Ph.D. degree in neuroscience from University of Rochester and M.S. degree in cell biology from Shanghai Institute of Cell Biology, Chinese Academy of Sciences. He has published extensively in the field of neuroscience including publications in prestigious journals such as Nature, Nature Medicine, Neuron and Stroke. He also served as the President of Sino-American Pharmaceutical Professional Association – Great Philadelphia.
This speaker's sessions: